Skip to main content

Month: February 2025

BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update

MELVILLE, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, announced today that it has changed the time for its previously announced webcasted conference call to discuss its pipeline update. The Company will now host the call at 10:30am EST on Thursday, February 27, 2025. To participate in the conference call by telephone, please dial 888-506-0062 (United States) or 973-528-0011 (International), participant access code 440089. The call will also be broadcast live and archived on the Investor section of the Company’s website at https://www.biorestorative.com/investor-relations/. About BioRestorative Therapies, Inc. BioRestorative (www.biorestorative.com)...

Continue reading

Banco Itaú Chile Files Material Event Notice Summoning to Annual Shareholders’ Meeting

SANTIAGO, Chile, Feb. 26, 2025 (GLOBE NEWSWIRE) — BANCO ITAÚ CHILE (SSE: ITAUCL) (the “Bank”) today announced that it filed a Material Event Notice with the Chilean Commission for the Financial Market reporting that the Bank scheduled its Annual Shareholders’ Meeting for April 24, 2025. The full Material Event Notice is available on the company’s investor relations website at ir.itau.cl. Investor Relations – Banco Itaú Chile IR@itau.cl / ir.itau.cl

Continue reading

Minim Martap Project Update

Canyon Continues Rapid Advancement Toward Production PERTH, Australia, Feb. 26, 2025 (GLOBE NEWSWIRE) — Canyon Resources Limited (ASX: CAY) (‘Canyon’ or the ‘Company’) is pleased to provide an update on key development workstreams at the Company’s flagship Minim Martap Bauxite Project (‘Minim Martap’ or ‘the Project’), located in Cameroon, as the Company continues to make rapid progress toward production. Minim Martap ranks among the world’s richest bauxite deposits, underpinned by an Ore Reserve of 109Mt at 51.1% total Al2O3 and 2.0% total SiO2 and a JORC Mineral Resource Estimate of 1,027Mt at 45.3% total Al2O3 and 2.7% total SiO2 The Definitive Feasibility Study (DFS) remains on schedule for completion in Q3 2025, with a focus on optimising operational efficiencies, ensuring sustainable economics and confirming the preferred...

Continue reading

Tintina Announces Appointment of Interim CEO

TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) — Tintina Mines Limited (“Tintina” or the “Company”) (TSXV: TTS) announces that Juan Enrique Rassmuss, who is a director of the Company, has been appointed as Interim Chief Executive Officer (“CEO”) to replace Mr. Eugenio Ferrari, CEO who is on medical leave. About Tintina Tintina Mines is a Canadian-based company with over two decades of experience in the junior mining sector, focused in the acquisition, exploration, and development of base and precious metal properties in South America and Canada. Recently, Tintina expanded its portfolio with the addition of five new projects in Chile, following the acquisition of a majority stake in Andean Belt Resources. Tintina is committed to advancing the exploration and development of the copper-gold (Cu-Au) Domeyko Sulfuros Project in the Atacama...

Continue reading

SJW Group Announces 2024 Financial Results

2024 reported diluted EPS of $2.87 and adjusted diluted EPS of $2.95, ahead of guidance 2025 estimated adjusted diluted EPS (non-GAAP) guidance of $2.90 to $3.001 Five-year capital plan increasing 25% to $2.0 billion2 to fund infrastructure replacement, PFAS remediation and additional water suppliesSAN JOSE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) — SJW Group (NASDAQ: SJW) today reported financial results for 2024. “I am pleased to report another year of strong performance, driven by our talented teams and a proven business strategy that delivers results,” stated SJW Group Chair, CEO, and President Eric W. Thornburg. “Our year-over-year EPS growth, exceeding our 2024 guidance, and substantial infrastructure investments demonstrate our commitment to building a strong foundation for sustainable growth. The regulatory outcomes in...

Continue reading

ThreeD Capital Inc. Releases Results for the Three and Six Months Ended December 31, 2024

TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce its unaudited results as at and for the three and six months ended December 31, 2024. As at December 31, 2024, the Company had cash, investments and digital assets of $42.3 million. As at December 31, 2024, net asset value per share was $0.76 as compared to $0.86 as at June 30, 2024. (See “Use of Non-GAAP Financial Measures” elsewhere) Financial Highlights for the three and six months ending December 31, 2024 with comparatives: Operating Results Three months endedDecember 31, Six months endedDecember 31,    2024     2023     2024     2023   Net...

Continue reading

Gogo to Report Fourth Quarter and Full Year 2024 Results on March 14, 2025

BROOMFIELD, Colo., Feb. 26, 2025 (GLOBE NEWSWIRE) — Gogo Inc. (NASDAQ: GOGO), the leading global provider of broadband connectivity services for the business aviation market, announced today that it will release its fourth quarter and full 2024 year financial results before the market opens on March 14, 2025. The Company will host a conference call with financial analysts the same day at 8:30 a.m. (ET). The Company filed a 12b-25 Notice of Late Filing with the SEC after the market close today stating Gogo will not be ready to file our 2024 Form 10-K by the deadline of March 3. Following the completion of the acquisition of Satcom Direct, the Company has taken additional time for the harmonization of financial statements across the newly combined organization. This form allows the Company an additional 15 days to file the Form 10-K. Conference...

Continue reading

Postal Realty Trust, Inc. Reports Fourth Quarter and Year End 2024 Results

– Introduces 2025 AFFO Guidance of $1.20 to $1.22 per diluted share –– Executed New Leases with 3% Annual Rent Escalations & Ten-Year Term –– 2024 Acquisitions of $91 Million at an Average Capitalization Rate of 7.6% –– Raised Dividend per share for Seventh Consecutive Year – CEDARHURST, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) — Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 2,000 properties leased primarily to the United States Postal Service (the “USPS”), ranging from last-mile post offices to industrial facilities, today announced results for the quarter and year ended December 31, 2024. Highlights for the Quarter Ended December 31, 2024Acquired 63 USPS properties for approximately $30.7...

Continue reading

Plymouth Industrial REIT Reports Fourth Quarter Results

BOSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) — Plymouth Industrial REIT, Inc. (NYSE: PLYM) (–“Plymouth” or the “Company”) today announced its financial results for the fourth quarter, fiscal year ended December 31, 2024 and other recent developments. Fourth Quarter, Full Year 2024 and Subsequent HighlightsReported results for the fourth quarter of 2024 reflect net income attributable to common stockholders of $3.25 per weighted average common share; Core Funds from Operations attributable to common stockholders and unit holders (“Core FFO”) of $0.46 per weighted average common share and units; and Adjusted FFO (“AFFO”) of $0.40 per weighted average common share and units. Reported results for the full year 2024 reflect net income attributable to common stockholders of $3.06 per weighted average common share; Core FFO of $1.83 per weighted...

Continue reading

Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter

Financial Results and Operational Update for Half-Year Ended December 31, 2024 NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided financial results and an operational update for the period ended December 31, 2024, “Our FDA approved product Ryoncil® will be available in the coming weeks to the children with SR-aGvHD in need of life-saving therapy,” said Dr. Silviu Itescu, Chief Executive of Mesoblast. “The treatment has delivered long-term survival outcomes in these very high-risk patients and we are pleased with the benefits and value that this treatment brings to patients and their healthcare providers at specialized transplant centers across the U.S.” Ryoncil® (remestemcel-L) U.S. Launch for Steroid-Refractory...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.